EVP, CRO & Pres. Life Sciences
Avg Cost/Share
$196.08
Shares
74
Total Value
$14,509.92
Owned After
16,506
SEC Form 4
EVP, CRO & Pres. Life Sciences
Avg Cost/Share
$193.36
Shares
75
Total Value
$14,502.00
Owned After
16,506
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$186.01
Shares
57
Total Value
$10,602.57
Owned After
16,506
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$181.03
Shares
58
Total Value
$10,499.74
Owned After
16,506
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$197.99
Shares
57
Total Value
$11,285.43
Owned After
16,506
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Feld Michael | BDX | EVP, CRO & Pres. Life Sciences | Dec 26, 2025 | Sell | $196.08 | 74 | $14,509.92 | 16,506 | |
| Feld Michael | BDX | EVP, CRO & Pres. Life Sciences | Dec 1, 2025 | Sell | $193.36 | 75 | $14,502.00 | 16,506 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Oct 27, 2025 | Sell | $186.01 | 57 | $10,602.57 | 16,506 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Sep 26, 2025 | Sell | $181.03 | 58 | $10,499.74 | 16,506 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Aug 22, 2025 | Sell | $197.99 | 57 | $11,285.43 | 16,506 |